Link to Poor Prognosis and Immune Infiltration of Head and Neck Squamous Cell Carcinomas

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2024 Dec 19

PMID 39697720

Authors

Churen Zhang

Jianguo Ke

Jia Li

Qiaoling Cai

Affiliations

Soon will be listed here.

Abstract

Background: Head and neck squamous cell carcinomas (HNSCs) are a diverse collection of tumors that originate in the oral cavity, pharynx, and larynx and pose a severe threat to human health, contributing to a fast-rising burden of cancer morbidity and mortality. The search for prognostic biomarkers of HNSC has been a hot topic. Spindle and kinetochore-associated () complex, including three members , which stabilize the spindle microtubules at the kinetosite during mitosis metaphase, has been demonstrated to be associated with poor prognosis of different cancers. The function of in HNSC remains to be investigated. We used a vast variety of public datasets and web-based technologies to investigate complex expression and its link to patient prognosis, and discovered multiple pathways by which the complex is regulated in HNSC.

Methods: The Cancer Genome Atlas (TCGA) database was used to determine expression level in HNSC. -related proteins level and immune cells infiltration level were identified. Metascape was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. GSE31056 from Gene Expression Omnibus (GEO) database was used as an external dataset for data validation. A nomogram containing for the prognosis of HNSC patients was established.

Results: were highly expressed in HNSC. High expression of was significantly related to the poor overall survival (OS) and poor disease-free survival (DFS) of HNSC patients. and the related proteins were enriched in cell division, chromosome segregation, and mitotic cell cycle. expression was obviously positively correlated to several immune cells' infiltration. The expression values of were higher in tumors than in healthy tissues in GSE31056.

Conclusions: were shown to be related to the prognosis and immune cell infiltration of HNSC, which could be used as biological markers and therapeutic targets for HNSC.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Marletta S, Fusco N, Munari E, Luchini C, Cimadamore A, Brunelli M . Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems. J Pers Med. 2022; 12(7). PMC: 9321150. DOI: 10.3390/jpm12071073. View

Wang D, Suo Y, Gong L, Lv S . SKA2 promotes proliferation and invasion of hepatocellular carcinoma cells via activating the β-catenin signaling pathway. Neoplasma. 2020; 67(4):743-750. DOI: 10.4149/neo_2020_190709N609. View

Lange K, Suleman A, Srayko M . Kinetochore Recruitment of the Spindle and Kinetochore-Associated (Ska) Complex Is Regulated by Centrosomal PP2A in . Genetics. 2019; 212(2):509-522. PMC: 6553828. DOI: 10.1534/genetics.119.302105. View

Wei M, Zhi J, Li L, Wang W . Predicting therapeutic responses in head and neck squamous cell carcinoma from mutation detected by cell-free DNA. Transl Cancer Res. 2024; 12(12):3604-3617. PMC: 10774070. DOI: 10.21037/tcr-23-878. View

Zheng B, Huang Z, Liu W, Zhao D, Xu X, Xiao S . A real-world evaluation of tislelizumab in patients with head and neck cancer. Transl Cancer Res. 2024; 13(2):808-818. PMC: 10928599. DOI: 10.21037/tcr-23-1502. View

Ren Z, Yang T, Zhang P, Liu K, Liu W, Wang P . SKA2 mediates invasion and metastasis in human breast cancer via EMT. Mol Med Rep. 2018; 19(1):515-523. DOI: 10.3892/mmr.2018.9623. View

Wang C, Liu S, Zhang X, Wang Y, Guan P, Bu F . SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer. Hereditas. 2022; 159(1):20. PMC: 9092687. DOI: 10.1186/s41065-022-00234-z. View

Chandrashekar D, Karthikeyan S, Korla P, Patel H, Shovon A, Athar M . UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022; 25:18-27. PMC: 8788199. DOI: 10.1016/j.neo.2022.01.001. View

10.

Zhao L, Jiang L, Du P, Zhang D, Liu Z, Li K . Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Acta Otolaryngol. 2016; 136(6):575-9. DOI: 10.3109/00016489.2016.1142117. View

11.

Tian F, Xing X, Xu F, Cheng W, Zhang Z, Gao J . Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer. Cancer Biother Radiopharm. 2015; 30(7):271-7. DOI: 10.1089/cbr.2014.1715. View

12.

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q . TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020; 48(W1):W509-W514. PMC: 7319575. DOI: 10.1093/nar/gkaa407. View

13.

Yu S, Ma J . Spindle and Kinetochore-Associated Complex Is Associated With Poor Prognosis in Adrenocortical Carcinoma. J Surg Res. 2022; 277:50-59. DOI: 10.1016/j.jss.2022.03.022. View

14.

Yang L, Chen Z, Liu Y, Wang X, Li J, Ye Q . Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2022; 14(17). PMC: 9454905. DOI: 10.3390/cancers14174099. View

15.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

16.

Wilson H, DAgostino Jr R, Meegalla N, Petro R, Commander S, Topaloglu U . The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma. Oncologist. 2020; 26(2):e279-e289. PMC: 7873320. DOI: 10.1002/onco.13573. View

17.

Windon M, DSouza G, Rettig E, Westra W, van Zante A, Wang S . Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Cancer. 2018; 124(14):2993-2999. PMC: 6033632. DOI: 10.1002/cncr.31385. View

18.

Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader G . GeneMANIA update 2018. Nucleic Acids Res. 2018; 46(W1):W60-W64. PMC: 6030815. DOI: 10.1093/nar/gky311. View

19.

Wilson B, Shen Q, Cescon D, Reedijk M . Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential. Front Genet. 2023; 14:1086163. PMC: 10095561. DOI: 10.3389/fgene.2023.1086163. View

20.

Brandt A, Thiele B, Schultheiss C, Daetwyler E, Binder M . Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2023; 15(7). PMC: 10093741. DOI: 10.3390/cancers15072051. View